Sustained mechanical and clinical functionality of the Flexhaler™ dry powder inhaler

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 21, Issue 4, 2008, Pages 381-388

  Lööf, Thomas ^a   Elfman, Peter ^a   Ström, Pelle ^a   Törngren, Anders ^a   Borgström, Lars ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Delivered dose; Flexhaler ; Functionality; Microbiology; Particle size; Performance; Turbuhaler

Indexed keywords

BUDESONIDE;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; HUMAN; INHALER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; COLONY COUNT, MICROBIAL; DRUG STABILITY; DRUG STORAGE; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MATERIALS TESTING; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 57149086943     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2008.0700     Document Type: Article

References (11)

1. Hilton S: An audit of inhaler technique among asthma patients of 34 general practitioners. Br J Gen Pract. 1990;40:505-506.
2. Goren A, Noviski N, and Springer C: The ability of young children to use a powder inhalation device (Bricanyl Turbuhaler) efficiently. Eur Respir J. 1991;4(Suppl. 14):242s.
3. Sinninghe Damsté HEJ: Turbuhaler - a clinical overview. In: Turbuhaler - A Non-CFC metered dose inhaler. Report of a symposium held at the 8th Congress of The International Society for Aerosols in Medicine, 1991, Davos, Switzerland. Exerpta Medica, Amsterdam, pp. 12-13, 1992.
4. Vogel H, and Wettmarshausen C. Auswirkungen der Inhalation eines Glukokortikoids mittels Treibgasdosieraerosol und mittels Turbohaler® - eine Röntgenpilotstudie. Pneumologie 1995;49:559-560.
5. Cochrane MG, Bala MV, Downs KE, Mauskopf J, and Ben-Joseph RH. Inhaled corticosteroids for asthma therapy - patient compliance, devices, and inhalation technique. Chest 2000;117:542-550.
6. Borgström L, Derom E, Ståhl E, Wåhlin-Boll E, and Pauwels R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med. 1996;153:1636-1640.
7. Olsson B, Borgstrîm L, and Asking L. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition. In: VR Dalby, P Byron, and S Farr (eds). Respiratory Drug Delivery. Interpharm Press Inc, Buffalo Grove, PA, pp. 273-281, 1996.
8. Yu D, Klein SA, and Reindl DT. An Evaluation of Silica Gel for Humidity Control in Display Cases. Western Association for Art Conservation WAAC Newsletter p. 23, 2001.
9. Lindsay DA, Russell NL, Thompson JE, Warnock TH, Shellshear ID, and Buchanan PR. A multicentre comparion of the efficacy of terbutaline Turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions. Eur Respir J. 1994;7:342-345.
10. Borgström L, Asking L, and Lipniunas P. An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions. J Aerosol Med. 2005;18:304-310.
11. Venekamp WJ, Kerr L, Dowsett SA, Johnson PA, Wimberley D, McKenzie C, Malone J, and Milicevic Z. Functionality and acceptability of a new electronic insulin injection pen with a memory feature. Curr Med Res Opin. 2006;22:315-325.